MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-GJ-01-0007588
Edkem Pharmaceuticals Limited - pharma in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹48.11 Cr
▲ 14% YoY
Net profit · FY 2025
₹3.22 Cr
Net margin 6.7%
EBITDA · FY 2025
₹6.14 Cr
EBITDA margin 12.8%
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹6.47 Cr
Issued & subscribed
Open charges
₹34.56 Cr
Secured borrowings
Company age
10 yrs
Est. 2016
Employees · EPFO
69
Provident fund records
About Edkem Pharmaceuticals Limited
Data last updated:
Edkem Pharmaceuticals Limited is a public limited company based in Ahmedabad, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24230GJ2016PLC092826. Its GSTIN is 24AAECE3248B1Z6 (Gujarat).
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.47 Cr. It was formerly known as Edkem Pharmaceuticals Private Limited. It is led by directors including Jitendra Ranpara and Basant Santoshkumar Agrawal.
Its last annual general meeting (AGM) was held on 04 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 145 – 148 (M9 – M12) Gallops Ind. Park – 2 VI. Chachrawadi Vasna Ta. Sanand, Ahmedabad, Gujarat, India – 380007.
As per the financials filed for FY 2025, the company reported a revenue of ₹48.11 Cr, a growth of 14% compared to the previous year. For the same year it recorded a net profit of ₹3.22 Cr (net margin 6.7%) and EBITDA of ₹6.14 Cr (EBITDA margin 12.8%). Revenue has grown at a compounded annual rate (CAGR) of 11% over three years and 39% over five years.
The company has about 69 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹34.56 Cr on record. Court records list 1 case involving the company, including 1 filed against it; 1 case is pending. The company has 4 deals on record (2 secondary share transfers, 1 funding round, 1 rights issue), with disclosed funding of ₹6.39 Cr; the latest was in September 2022. Its 7 peer companies in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Protech Bio Systems Private Limited with revenue of ₹48.99 Cr.
Edkem Pharmaceuticals Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0007588). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website edkempharma.in.
Company details
CIN U24230GJ2016PLC092826
Registration Number 092826
Incorporation Date 06 July 2016
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 04 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-01-0007588
CIN history
Edkem Pharmaceuticals has one previous CIN (Corporate Identification Number): U24230GJ2016PTC092826. The current CIN is U24230GJ2016PLC092826, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24230GJ2016PLC092826 | Current |
| U24230GJ2016PTC092826 | Previous |
Key People
Jitendra Ranpara Director Basant Santoshkumar Agrawal Director Santoshkumar Jamnaprasad Agrawal Director Recognitions & Rankings of Edkem Pharmaceuticals
Contact details
Edkem Pharmaceuticals Limited's registered office is in Ahmedabad, Gujarat. Its website is edkempharma.in. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address145 – 148 (M9 – M12) Gallops Ind. Park – 2 VI. Chachrawadi Vasna Ta. Sanand, Ahmedabad, Gujarat, India – 380007
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Edkem Pharmaceuticals Limited, buy the company report.
Comprehensive company report
Edkem Pharmaceuticals Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Edkem Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Edkem Pharmaceuticals Limited, buy the company report.
Financials of Edkem Pharmaceuticals Limited
FY 2025 filings availableEdkem Pharmaceuticals Limited reported revenue of ₹48.11 Cr (up 14% YoY) for FY 2025.
Revenue · FY 2025
₹48.11 Cr ▲ 14%
Net profit · FY 2025
₹3.22 Cr margin 6.7%
EBITDA · FY 2025
₹6.14 Cr margin 12.8%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 14%
3 years · compounded
▲ 11%
5 years · compounded
▲ 39%
EBITDA CAGR growth
1 year
▲ 24%
3 years · compounded
▲ 15%
5 years · compounded
▲ 41%
Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 14% growth in the latest year. EBITDA rose 24% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.14 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹3.22 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 12.8% | ||||
| Net Profit Margin | 6.7% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Edkem Pharmaceuticals Limited, buy the company report.
Board of directors of Edkem Pharmaceuticals Limited
Edkem Pharmaceuticals has 4 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jitendra Ranpara | Director | 23 Mar 2019 | 7 Years 7 Months | Current |
| Basant Santoshkumar Agrawal Also directs: Brukem Life Care Private Limited | Director | 06 Jul 2016 | 10 Years 4 Months | Current |
| Santoshkumar Jamnaprasad Agrawal Also directs: Eden Health Care Private Limited | Director | 06 Jul 2016 | 10 Years 4 Months | Current |
| Ankita Basant Agrawal | Director | 12 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
Edkem Pharmaceuticals Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Protech Bio Systems Private Limited | ₹48.99 Cr (FY 2025) | -17.0% | New Delhi, Delhi, India | |||
| Sainor Pharma Private Limited | ₹48.47 Cr (FY 2016) | 0.0% | Hyderabad, Telangana, India | |||
| Glow Pharma Private Limited | ₹48.18 Cr (FY 2025) | 23.0% | Mumbai, Maharashtra, India | |||
| Rhydburg Pharmaceuticals Ltd | ₹48.17 Cr (FY 2024) | 26.0% | Delhi, India | |||
| Edkem Pharmaceuticals Limitedthis company | ₹48.11 Cr (FY 2025) | ₹3.22 Cr | 6.7% | 14.0% | 69 | Ahmedabad, Gujarat, India |
| Indasi Lifescience Private Limited | ₹48.01 Cr (FY 2025) | 25.0% | Daman, Daman and Diu, India | |||
| R.K. Laboratories Private Limited | ₹47.96 Cr (FY 2024) | 10.0% | Chandigarh, India | |||
| Biddle Sawyer Limited | ₹47.93 Cr (FY 2025) | -28.0% | Mumbai, Maharashtra, India |
To see the full peer comparison of Edkem Pharmaceuticals Limited, buy the company report.
Auditor
Edkem Pharmaceuticals Limited is audited by KPSJ & ASSOCIATES LLP for the financial year 2025.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KPSJ & ASSOCIATES LLP | FY 2025 | 124845W/ W100209 |
Shareholding
The shareholding of Edkem Pharmaceuticals Limited is on record for 5 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Edkem Pharmaceuticals Limited, buy the company report.
Charges & borrowings
Open charges
₹34.56 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 12 Dec 2017 | 100142248 | Axis Bank Limited | ₹17.28 Cr | Open | |
| 08 Dec 2017 | 100142247 | Axis Bank Limited | ₹17.28 Cr | Open |
To see the full charge records of Edkem Pharmaceuticals Limited, buy the company report.
Total charge records: 2 View all charges
Deals & funding
Edkem Pharmaceuticals Limited has 4 deals on record (2 secondary share transfers, 1 funding round, 1 rights issue), with disclosed funding of ₹6.39 Cr; the latest was in September 2022.
Total deals
4
Secondary share transfers
2
Funding round
1
Rights issue
1
Disclosed funding
₹6.39 Cr
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Sep 2022 | Secondary share transfer | Undisclosed | Buyer: 3 individuals Seller: Surabhi Organics Private Limited, Mahaveer Online Private Limited , an individual |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: Prakash Parekh Huf |
| Mar 2019 | Rights issue | ₹7 Lakh | Investors: Prakash Parekh Huf, 2 individuals |
| Mar 2017 | Funding round | ₹6.39 Cr | Investors: Edan Health Care Private Limited, Surabhi Organics Private Limited, 2 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Edkem Pharmaceuticals Limited has 1 court case on record: 1 filed against it. All case is pending.
Total cases
1
Filed against the company
1
Pending
1
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 1 | 1 | 1 |
Cases on record (1 of 1)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Ranchi, Jharkhand | Court case (DrugCosmetic) | Filed against the company by State of Jharkhand | Pending |
To see the full case history of Edkem Pharmaceuticals Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Edkem Pharmaceuticals Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Edkem Pharmaceuticals Limited has a workforce of 69 employees on its EPFO records as of Jan 18, 2026, across 1 active EPFO establishment.
Employee count
69
Active EPFO establishments
1
Employee growth
1.47%
GST
Edkem Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAECE3248B1Z6 | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Edkem Pharmaceuticals Limited, buy the company report.
Recent activity
Edkem Pharmaceuticals Limited has 6 board changes on record since 2016: 4 appointments and 2 cessations. The latest: Jitendra Ranpara ceased to be Additional Director on 29 Apr 2019.
AGM
Edkem Pharmaceuticals Limited last Annual general meeting of members was held on 04 Sep 2025 as per latest MCA records.
Charges
A charge with Axis Bank Limited of Rs. 17.28 Cr registered on 12 Dec 2017 with Charge ID 100142248 was modified on 14 Jul 2025.
Charges
A charge with Axis Bank Limited of Rs. 17.28 Cr registered on 08 Dec 2017 with Charge ID 100142247 was modified on 02 Jul 2025.
Filing
Edkem Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Jitendra Ranpara ceased to be Additional Director.
Appointed
Jitendra Ranpara was appointed as Director.
Appointed
Ankita Basant Agrawal was appointed as Director.
Ceased
Ankita Basant Agrawal ceased to be Additional Director.
Charges
A charge with Axis Bank Limited amounted to Rs. 17.28 Cr with Charge ID 100142248 was registered on 12 Dec 2017.
Charges
A charge with Axis Bank Limited amounted to Rs. 17.28 Cr with Charge ID 100142247 was registered on 08 Dec 2017.
Appointed
Basant Santoshkumar Agrawal was appointed as Director.
Appointed
Santoshkumar Jamnaprasad Agrawal was appointed as Director.
1 earlier event is in the company report.
Frequently asked questions
Edkem Pharmaceuticals is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 July 2016 (10+ years old) and is registered under CIN U24230GJ2016PLC092826.
Edkem Pharmaceuticals has 4 current directors:
- Jitendra Ranpara - Director
- Basant Santoshkumar Agrawal - Director
- Santoshkumar Jamnaprasad Agrawal - Director
- Ankita Basant Agrawal - Director
The latest financial statements of Edkem Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 04 September 2025. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Edkem Pharmaceuticals is 24AAECE3248B1Z6, registered in Gujarat.
The CIN (Corporate Identification Number) of Edkem Pharmaceuticals is U24230GJ2016PLC092826. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Edkem Pharmaceuticals has 1 court case on record: 1 filed against it. 1 is pending.
Edkem Pharmaceuticals was incorporated on 06 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Edkem Pharmaceuticals has 4 deals on record (2 secondary share transfers, 1 funding round, 1 rights issue), with disclosed funding of ₹6.39 Cr; the latest was in September 2022.
The peers of Edkem Pharmaceuticals by revenue are Protech Bio Systems Private Limited, Sainor Pharma Private Limited, Glow Pharma Private Limited, Rhydburg Pharmaceuticals Ltd, Indasi Lifescience Private Limited and 2 more, all in the Pharma industry (Formulations, Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Jitendra Ranpara ceased to be Additional Director on 29 Apr 2019. Jitendra Ranpara was appointed as Director on 23 Mar 2019. Ankita Basant Agrawal was appointed as Director on 12 Jun 2018. Edkem Pharmaceuticals has 6 board changes on record in total.
Yes, Edkem Pharmaceuticals is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-01-0007588).
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages